Saturn V Capital Management LLC Portfolio Holdings

Saturn V Capital Management LLC

  • $456 Billion
  • Q3 2025

Saturn V Capital Management LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $456 Billion distributed in 17 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Abivax Sa with a value of $68B, Amylyx Pharmaceuticals, Inc. with a value of $62.6B, Jazz Pharmaceuticals PLC with a value of $39.6B, Dyne Therapeutics, Inc. with a value of $33.8B, and Cogent Biosciences, Inc. with a value of $29.1B.

Examining the 13F form we can see an increase of $209B in the current position value, from $247B to 456B.

Saturn V Capital Management LLC is based out at Austin, TX

Below you can find more details about Saturn V Capital Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $456 Billion
Healthcare: $308 Billion

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 17
  • Current Value $456 Billion
  • Prior Value $247 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 2 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email